Company / Current Assets
Bio-Rad Laboratories Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$2.9B
FY2025
5-year range
$2.0B / $3.2B
FY2021-FY2025
Trend
-4.1%
vs FY2024
Sector context
#38 of 160
Health Care
What the data says
Bio-Rad Laboratories's current assets of $2.9B is higher than 76% of companies in the Health Care sector (FY2025). Current Assets has declined for 3 consecutive years, from $3.2B in FY2022 to $2.9B in FY2025.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +6.3%. Top quartile in the Health Care sector.
Declined from $3.0B to $2.9B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 160This company $2.9B Sector average $5.2B
▼
-44.5% below sector average
Key checks
Key Insights
- Bio-Rad Laboratories's current assets has declined for 3 consecutive years.
- 5-year CAGR of +6.3%, indicating consistent growth.
- In FY2025, current assets decreased 4.1% year-over-year.
- Ranks #38 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | -4.1% |
| FY2024 | $3.0B | -0.6% |
| FY2023 | $3.0B | -3.5% |
| FY2022 | $3.2B | +58.7% |
| FY2021 | $2.0B | -7.0% |
| FY2020 | $2.1B | -1.8% |
| FY2019 | $2.2B | +7.7% |
| FY2018 | $2.0B | +2.4% |
| FY2017 | $2.0B | +7.2% |
| FY2016 | $1.8B | +3.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026